Biogen (BIIB) was upgraded to buy at Citigroup. $305 price target. There seems to be an attractive risk/reward for the MS product line, Citi said.
Caterpillar (CAT) was upgraded to overweight at Barclays. $110 price target. The valuation is more attractive, as 2018 earnings estimates are well-above consensus, Barclays said.
Sysco (SYY) was upgraded to outperform from neutral at Credit Suisse. $59 price target. The recent selloff has created a buying opportunity, as management recently boosted guidance, Credit Suisse said.
Stock Comments and EPS Changes
Shares of Apple (AAPL) are now seen reaching $154 at Canaccord Genuity. The iPhone appears to be gaining market share and Canaccord has a buy rating on the stock.
Shares of Micron (MU) are now seen reaching $30, according to Nomura. Earnings estimates were also increased, given strong DRAM pricing, Nomura said. The analysts also have a buy rating on the stock.